Tip of the Month, July 2010 - Managing the Risks and Costs of Preserving and Producing Structured Data from Databases
27 July 2010
Mayer Brown Newsletter
Scenario A large pharmaceutical company maintains data related to its research and development in several proprietary, structured databases. The information contained in the database is regularly updated with results of new trials. The company receives a subpoena from a regulatory agency requesting documents related to clinical trials that were completed in advance of releasing a new product. To fully respond to the subpoena, information maintained in those databases must be collected, reviewed and potentially produced.